WOMEN CEO REPORT

Reshma Kewalramani M.D. - Vertex Pharmaceuticals

Reshma Kewalramani M.D.

Vertex Pharmaceuticals

Reshma Kewalramani is no newcomer to the field of medicine. Kewalramani received her medical degree from the Boston University School of Medicine and completed a General Management Program at Harvard University, both of which have prepared her for roles in the C-Suite. Prior to Vertex, Kewalramani worked at Amgen for over twelve years, three of which she served as Vice President of the company. Her passion for helping patients and commitment to R&D has led the team at Vertex to develop remarkable advances in medicine for treating debilitating diseases such as cystic fibrosis (CF), alpha-1 antitrypsin deficiency, APOL1-mediated kidney diseases, sickle cell disease, and beta- thalassemia.

Year appointed: 2020